Purification and spectroscopic characterization of a recombinant amino-terminal polypeptide fragment of mouse epithelial cadherin  by I. Tong, Kit et al.
FEBS Letters 352 (1994) 318-322 
FEBS 14595 
Purification and spectroscopic haracterization of a recombinant 
amino-terminal polypeptide fragment of mouse epithelial cadherin 
Kit I. Tong”, Patrick Yaua, Michael Overduin”, Stefan Bagby”, Tudor Porumba, 
Masatoshi Takeichib, Mitsuhiko Ikuraa,* 
“Division of Molecular and Structural Biology, Ontario Cancer Institute and Department of Medical Biophysics, University of Toronto, 
Toronto, Ont., Canada 
bDepartment of Biophysics, Faculty of Science, Kyoto University, Kitashirakawa, Sakyo-ku. Kyoto 606, Japan 
Received 10 August 1994 
Abstract Cadherins are a family of Ca”-dependent cell adhesion molecules containing four extracellular tandem repeats each of 110 amino acids. 
The most amino-terminal repeat is believed to confer the specificity of cell adhesion. A polypeptide containing the amino-terminal repeat of mouse 
epithelial cadherin has been over-expressed in E. coli and purified to homogeneity. This polypeptide binds Ca2’ with a dissociation constant of 
1.6 x 10m4 M. CD and NMR experiments indicate that the polypeptide adopts a predominantly/3_sheet conformation and that binding of Ca” induces 
only small conformational changes. 
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1. Introduction 
Cadherins are a family of cell-cell adhesion molecules that 
are crucial for the physical association of vertebrate cells (for 
reviews see [ 141). Cadherins mediate Ca”-dependent cell adhe- 
sion through homophilic binding interactions. For example, 
epithelial (E-) cadherin binds selectively to E-cadherin, and 
neural (N-) cadherin recognizes N-cadherin. These homophilic 
interactions have been implicated in the preferential adhesion 
and sorting of cells during morphogenesis. The molecular basis 
of cadherin-mediated cell adhesion specificity is poorly under- 
stood, but depends on structural characteristics of the extracel- 
lular regions of cadherins. 
The N-terminal extracellular egion of cadherins consists of 
four cadherin or CAD repeats, each of approximately 110 
amino acid residues, followed by a cysteine-rich domain (Fig. 
1). Analyses using chimeric cadherins [5] showed that the most 
N-terminal CAD repeat (CADl) is crucial for cadherin speci- 
ficity. In particular, a region containing the conserved HAV 
tripeptide (residues 80-82) has been suggested to be responsible 
for binding specificity [6]. Each CAD repeat contains Asp/Glu 
clusters of similar size and distribution which constitute puta- 
tive Ca”-binding sequences differing from the Ca*‘-binding 
motif of the EF-hand superfamily of proteins [7]. Ringwald et 
al. [8] reported that an 84 kDa tryptic fragment consisting of 
almost the entire extracellular region of uvomorulin (E-cad- 
herin) indeed binds Ca*‘. Ozawa et al. [9] demonstrated that a 
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single amino acid substitution in a putative Ca*‘-binding site 
inactivates the adhesive function of E-cadherin. These and 
other [1,8,9] results clearly demonstrate the absolute require- 
ment for Ca” ions in cadherin-mediated cell adhesion. CAD 
repeats have been identified in many other integral membrane 
proteins, including desmosomal cadherins [lO,ll], the proto- 
oncoprotein tyrosine kinase RET [12,13], and the Drosophila 
tumour suppressor protein FAT [14]. 
Despite the growing interest in cadherin-mediated cell adhe- 
sion, little is known about the structural and biophysical prop- 
erties of cadherins. Herein we present the purification, Ca2’- 
binding properties, and CD and NMR structural characteriza- 
tions of the N-terminal 145residue polypeptide fragment (re- 
ferred to as E-CADl) of mouse E-cadherin [ 15,161. This 
E-CAD 1 fragment (Fig. 1) comprises the entire sequence of the 
CAD1 repeat, including putative Ca2’-binding sites and the 
proposed adhesion recognition site [5,6], providing an excellent 
candidate for studying the structural basis of Ca*‘-dependent 
cell adhesion mediated by E-cadherin. 
2. Materials and methods 
2.1. Plasmid construction and over-expression 
The plasmid for over-expression of E-CAD1 of mouse E-cadherin 
was constructed by inserting the portion of the cDNA encoding amino 
acids Rl-A145 [15], as well as an N-terminal methionine into the PAS 
expression vector [17] using standard PCR procedures. The sense 
primer used for the PCR included a BspHI site and the antisense primer 
included a termination codon and an XbaI site. The amplified product 
was first inserted at the SmaI site of pTZ18R (Pharmacia) and then 
removed from the resulting plasmid at BspHI and XbaI. This DNA 
fragment was inserted into the PAS expression vector at the NcoI and 
XbaI sites by uni-directional ligation (Fig. 1). The resulting plasmid, 
pmE-CADl, contains the kP,P, promoter and is under control of the 
thermosensitive ;IcI repressor. 
For over-expression of E-CADI, E. coli strain AR58 [17] was trans- 
formed with pmE-CAD1 and grown at 37°C in M9 minimal medium 
(0.5% (w/v throughout) o-glucose, 0.1% NH&I, 0.05% NaCI, 0.6% 
Na,HPO,, 0.3% KH,PO,, I mM MgSO,, 0.1 mM CaCl,, pH 7.4) 
supplemented with 2 x 10e4% thiamine, 2 x 10m4% o-biotin, and 100 
,&ml ampicillin. When an OD, of 0.8 was reached, the temperature 
0014-5793/94/$7.00 0 1994 Federation of European Biochemical Societies. All rights reserved. 
SSDI 0014-5793(94)00982-l 
K.I. Tong et al. IFEBS Letters 352 (1994) 318-322 319 
was increased to 42’C to induce the production of the E-CAD1 frag- 
ment. After 3 h of induction, the cells-were harvested by centrifugation 
at 6000 x P for 20 min and then stored at - 70°C. For “N-1abelling of 
E-CADl,“NH,Cl (Isotec) was used as the sole nitrogen source in-M9 
minimal medium. 
3. Results and discussion 
2.2. Purification 
All purification steps were carried out at 4°C. The frozen cells were 
suspended in 3/80 (v/v) of the original culture volume using buffer A 
(50 mM Tris-HCl, pH 7.9 containing 5% glycerol, 1 mM EDTA, 1 mM 
DTT, 1 mM PMSF), 50 mM NaCl, 0.01 mg/ml pepstatin, 0.01 mg/ml 
leupeptin, l%(v/v) aprotinin, lOpg/ml DNase I, O.l%(v/v) Nonidet P40. 
The suspended cells were lysed by sonication on ice using a Branson 
Sonifier Model 450 sonicator. Cell debris was removed by ultracentrifu- 
gation at 46,500 x g for 20 min. Approximately 80% of E-CAD1 re- 
mained in the soluble fraction, as judged by “‘Ca blot assay (see below). 
An equal volume of buffer A was added to the supematant prior to 
loading onto a DEAE-Sepharose (Pharmacia) column (2.5 x 15 cm). 
The column was washed extensively with buffer A containing 25 mM 
NaCl and the adsorbed proteins were eluted using a NaCl gradient 
(25-125 mM) in buffer A. E-CAD1 eluted at 85-100 mM NaCl. Frac- 
tions containing E-CAD1 were pooled and concentrated using Cen- 
triprep 10 conc&trators (Amicon). The concentrated solution was ap- 
plied to a Senhacrvl S-100HR (Pharmacia) column (2.5 x 88 cm) equil- 
ibrated with-O.2 h;I NaCl in duffer A. Fractions containing E:CADl 
(Fig. 2A) were pooled and concentrated again as before. The protein 
sample was further purified using FPLC (fast protein liquid chromatog- 
raphy) (Pharmacia) with a Mono Q HR 5/5 column and eluted using 
a NaCl gradient (25-125 mM) in buffer A, over 50 ml at a flow rate 
of 0.5 ml/min. The E-CAD1 polypeptide purified in this manner was 
at least 95% homogeneous, as judged by tricine 15% SDS-PAGE (Fig. 
2B) and one- and two-dimensional NMR spectra. The identity of the 
purified product was checked by amino acid analysis and electrospray 
ionization mass spectrometry. The yield of E-CAD1 was approximately 
5 mg per 1 of M9 minimal medium. 
2.3. Cd’binding and chemical cross-linking 
The ?a blot assay was performed by transferring electrophoreti- 
tally separated proteins onto a polyvinylidene difluoride membrane 
(DuPont) followed by labelling with 45CaC1, (DuPont) and subsequent 
autoradiography [18]. 
Ca”-binding measurements were performed at 23°C using a home- 
built flow dialysis apparatus. The experimental details are the same as 
described previously [19]. The dialysis solution contained 1 .O mM pro- 
tein in 20 mM Tris-HCl, 0.1 M KCl, 10 mM DTT, pH 7.0. The 
experimental data was fitted to a polynomial curve using extensions of 
the non-linear regression computer program Enzfitter [20], and a mid- 
point of the calculated curve is reported as the dissociation constant. 
Chemical cross-linking analysis was performed both in the absence 
and in the presence of 10 mM Ca2+ using the procedure described 
previously [21]. The purified E-CAD1 (30, 150,500 PM) was incubated 
In the abse& or presence of 0.001% or 0.01% glutaraldehyde for 15 
min at 37°C. The results were analyzed using tricine SDS-PAGE and 
subsequent 45Ca blot assay as descr>bed above. Comparable amounts 
of ribonuclease A, bovine serum albumin, and a fragment of the p53 
oligomerization domain (Y. Yin and C. Arrowsmith, unpublished) 
were used as negative (the former one) and positive (the letter two) 
controls. 
2.4. CD and NMR measurements 
CD measurements were performed at 22°C using a Jasco J-720 spec- 
tropolarimeter and 1 .O mm path length cells with the following parame- 
ters: scan speed 50 nrn/min, response time 1 s, and bandwidth of 1 nm. 
A standard noise reduction routine was employed. The concentration 
of the protein was 8 PM in H,O (pH 7.0) in the presence or absence of 
5 mM CaCl,. 
NMR experiments were carried out with a sample containing ap- 
proximately 1.5 mM unlabelled or uniformly 15N-enriched E-CAD1 in 
95%/5% H20/D,0 containing 20 mM [‘H,,]Tris-HCl (MSD Isotopes), 
pH 7.0, 0.1 M KCl, 10 mM [‘H,,]DTT (MSD Isotopes), and 0.1 mM 
NaN,. One-dimensional ‘H and sensitivity-enhanced ‘H “N HSQC [22] 
two-dimensional NMR spectra were recorded on Varian UNITY-600 
and UNITY-plus 500 spectrometers. 
With the aim of obtaining large quantities of individual cad- 
herin repeats for biophysical and structural characterization, 
several truncated cDNAs were cloned into the PAS expression 
vector [17]. Among those tested in our laboratory, E-CAD1 
(Fig. 1) gave high level expression and high solubility in E. coli 
(see section 2). The procedure used for the purification of 
E-CAD1 consists of three column chromatography steps. 
E-CAD1 was first purified to approximately 80% by DEAE- 
Sepharose ion-exchange followed by Sephacryl S-100HR gel- 
filtration. The elution profile of the S-100HR column is shown 
in Fig, 2. The E-CAD1 fractions contained some minor compo- 
nents of lower molecular weight, which were removed by FPLC 
using a Mono Q column. This procedure resulted in E-CAD1 
of >95% purity. The purified product showed a single SDS- 
PAGE band which contained Ca*‘-binding activity, as judged 
by the 45Ca blot assay (Fig. 2). It should be noted that although 
E-CAD1 migrated at 20 kDa, the calculated M, of 16,135 was 
confirmed by electrospray ionization mass spectrometry. 
In order to assess the possibility that E-CAD 1 forms a dimer 
or a multimer, native gel-electrophoresis and chemical cross- 
linking experiments were performed (data not shown). The 
native gel (both in the absence and in the presence of 10 mM 
Ca”) yielded a single band at various E-CAD1 concentrations 
between 10 and 500 ,uM. Chemical cross-linking experiments 
of E-CAD1 (30-500 PM) with glutaraldehyde, both in the ab- 
sence and in the presence of 10 mM Ca*‘, yielded no higher 
molecular weight products. These results suggest hat E-CAD1 
is predominantly monomeric in solution. This was further sup- 
ported by “N linewidth measurements using ‘H 15N HSQC 
spectroscopy, in which the overall rotational correlation time 
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Fig. 1. A schematic diagram of E-CAD1 and the modular structure of 
E-cadherin, together with the amino acid sequence of E-CAD1 [l]. The 
extracellular cadherin repeats are denoted as CADl, CADZ, CAD3, 
and CAD4. The cysteine-rich, membrane spanning, and cytoplasmic 
regions are denoted as CYS, TM, CYT, respectively. The cloning sites 
which join the truncated E-CAD1 gene [15] to the PAS expression 
vector [17] are indicated. The putative Cal’-binding sites [1,8] are high- 
lighted by bold letters and the consensus HAV sequence [1,6] by bold 
letters and a box. 
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Fig. 2. (A) Sephacryl S-100HR gel-filtration column chromatography 
of E-CADl. The horizontal bar with arrows indicates the E-CAD1 
fractions. The flow rate was 15 ml/h and the fraction size was 4 ml/tube. 
(B) SDS-PAGE of E-CADl. A 15% gel in Tris-Tricine buffer system 
was used. (a) Total soluble extract from E. coli after 3 h induction at 
42°C; (b) E-CAD1 fraction purified using the procedure described in 
section 2; (c) autoradiogram of a ‘%a blot of the same fraction as that 
in lane b. 
of E-CAD1 was estimated to be that of a protein of 1 S-20 kDa. 
This correlation time did not change dramatically upon the 
addition of 10 mM Ca”, suggesting no Ca*‘-dependent mul- 
timerization by E-CAD 1. 
The Ca” binding properties of E-CAD1 were studied by the 
flow dialysis method [19]. The Ca2’ binding curve of E-CAD1 
obtained by this method is shown in Fig. 3. The dissociation 
constant (Z&) for Ca2’ was found to be 1.6 x 10m4 M. This value 
is lower than the value (2 x 10m3 M) previously obtained with 
a 13-residue synthetic peptide comprising a putative Ca2’ bind- 
ing site from E-cadherin (uvomorulin) [7,23], suggesting that 
E-CAD1 forms a structurally stable conformation better suited 
to Ca2’ ligation than the 13-residue peptide. On the other hand, 
the Kd value obtained for E-CAD1 is higher than those (lo-‘- 
lo-’ M) of the intracellular EF-hand Ca2’-binding proteins, 
consistent with a millimolar concentration of extracellular 
Ca”. Due to the technical imitation associated with high disso- 
ciation constants in flow dialysis, the exact stoichiometry of 
Ca2’ bound to E-CAD1 remains to be determined by other 
methods. The amino acid sequence suggests that E-CAD 1 con- 
tains at least two conserved putative Ca”-binding regions [ 181, 
DQNDN (residues 102-106) and DADDD (residues 136140). 
It is possible that these regions form two separate sites or that 
both together contribute to a single Ca2’-binding site. 
To study the conformational properties of E-CAD1 in re- 
sponse to Ca” binding, CD and NMR experiments have been 
performed. The CD spectra of E-CAD1 in the absence and in 
the presence of Ca” are shown in Fig. 4A. The positive ellip- 
ticity at 234 nm in the spectra indicates that E-CAD1 contains 
a large percentage of /I-sheet conformation. The addition of 
Ca” yielded no significant change at 234 nm but some pertur- 
bation in the range 190-220 nm. These results suggest hat most 
of the B-sheet conformation is present both in the absence and 
in the presence of Ca2’, but subtle structural changes may be 
occurring upon binding of Ca2+. This is consistent with Ca2’ 
titration data using fluorescence spectroscopy in which trypto- 
phan fluorescence intensity changes only -0.5% upon the addi- 
tion of Ca2’ (J. Ames, unpublished results). 
The ‘H NMR spectrum of E-CAD1 in the presence of 10 mM 
Ca2’ is shown in Fig. 4B. During the course of NMR experi- 
ments, it was found that E-CAD1 is unstable at temperatures 
higher than 30°C. Therefore, NMR experiments were per- 
formed at 23”C, at which temperature E-CAD1 retained a 
folded conformation for 2-3 weeks. There are a number of 
high-field shifted proton resonances from - 1.1 to 0.5 ppm and 
also downfield shifted amide proton resonances from 9.0 to 
10.2 ppm, indicating that the protein has a defined tertiary 
structure under the conditions used for the experiment. The 
presence of several downfield-shifted Ha proton resonances, to 
the left-hand side of the strong water signal (4.8 ppm), is char- 
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PCs 
Fig. 3. Ca”-binding profile of E-CAD], obtained using the flow dialy- 
sis method. The vertical scale for Ca2’ bound to E-CAD1 is normalized 
to unity. The experimental details are given in section 2. 
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Fig. 4. (A) CD spectrum of E-CADI in the absence (solid line) and in the presence (broken line) of 5 mM CaCI2, pH 7.0. (B) 500 MHz IH NMR 
spectrum of E-CADI in 95% H20/5% D20, 10 mM CaCI2, pH 7.0. A presaturation field was used to reduce the water signal. Other conditions are 
described in section 2. 
acteristic offl-sheet conformation, consistent with the CD data 
described above. The 1H NMR spectrum of Ca2+-free E-CAD 1 
(data not shown) was very similar to that shown in Fig. 4B, 
suggesting that binding of Ca 2÷ does not induces major confor- 
mational changes, again in agreement with the CD and fluores- 
cence data. 
tH 15N HSQC spectra have been recorded with 15N-enriched 
E-CAD1 in the absence and in the presence of Ca 2+ (data not 
shown). The spectra re very similar to each other, although 
6 out of 134 cross-peaks are significantly shifted upon the 
addition of Ca 2+. This observation suggests that Ca2+-depend - 
ent conformational changes are localized, presumably close to 
the Ca2+-binding site(s). These small changes in the NMR spec- 
tra induced by Ca 2+ contrasts with results from other Ca 2+- 
binding proteins, such as calmodulin [24,25], troponin C [26], 
calbindin D9k [27], and the bacterial spore coat Ca2+-binding 
protein S [28,29], all of which show more dramatic Ca2+-in - 
duced spectral changes. Protein S is a soluble extracellular 
Ca2+-binding protein from Myxococcus xanthus, known to be 
involved in Ca2+-dependent spore-spore interactions [30]. It is 
interesting to note that, like E-CAD1, this extracellular Ca 2+- 
binding protein consists mainly of fl-sheet conformation 
[28,29], in contrast with the intracellular ~z-helical, EF-hand 
Ca2+-binding proteins such as calmodulin, troponin C, and 
calbindin D9k. 
4. Conclusions 
Until now, it has been unclear whether or not a single CAD 
repeat forms a structural domain and binds Ca 2+. The present 
study reveals that the N-terminal CAD1 repeat of E-cadherin 
indeed forms an independent structural domain and has a mod- 
erate Ca2+-binding activity (Ka = 1.6 x 10 -4 M), sufficient o 
bind Ca 2+ under physiological conditions in the extracellular 
matrix. Furthermore, CD and NMR data provide vidence that 
the structure of this single cadherin repeat consists predomi- 
nantly of a fl-sheet conformation. 
It has been reported [1,3,6] that the CAD1 domain plays an 
important role in determining the specificity of cadherin-medi- 
ated cell adhesion. The monomeric state of the isolated 
E-CADI repeat, however, suggests that cell-cell interaction 
mediated by E-cadherin may involve more than one extracellu- 
lar repeat. Dimerization might have been expected if molecules 
of a single CAD repeat were able to self-associate. Interestingly, 
isolated single adhesive domains of other cell adhesion mole- 
cules such as CD2 [31] and CD4 [32] were also found to be 
monomeric in solution. Furthermore, a number of previous 
observations [14] indicate that other portions of the cadherin 
molecule are necessary for cell adhesive function. For example, 
tight cell-cell junctions mediated by cadherin interactions may 
require anchoring to a complex of cytoskeletal proteins through 
the cytoplasmic domain and also possibly molecular clustering 
via lateral interactions in the plasma membrane [33,34]. The 
present study supports this view in that a single CAD repeat 
itself does not form a stable dimer or an oligomer. 
The availability of large amounts of E-CAD 1 will allow de- 
termination of the three-dimensional structure of this impor- 
tant domain using NMR or X-ray crystallography. The present 
biochemical nd biophysical studies establish a starting point 
towards our ultimate goal of detailed structural and functional 
characterization f E-CAD1, and consequent insights into the 
molecular mechanism of cadherin-mediated c lladhesion. 
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